Clinical, histopathological and prognostic features of primary cutaneous acral CD8
Journal
The British journal of dermatology
ISSN: 1365-2133
Titre abrégé: Br J Dermatol
Pays: England
ID NLM: 0004041
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
revised:
27
11
2021
received:
24
10
2021
accepted:
30
12
2021
pubmed:
7
1
2022
medline:
6
5
2022
entrez:
6
1
2022
Statut:
ppublish
Résumé
The differential diagnosis of atypical dermal nonepidermotropic CD8 To assess the clinical, histological and immunophenotypic features; outcomes of; and differences between dermal CD8 Retrospective analysis of a series of 46 patients and biopsies by the international EORTC Cutaneous Lymphoma Group. The dermal CD8 A constellation of distinct clinical, histopathological and phenotypic features allows discrimination and assignment of dermal CD8
Sections du résumé
BACKGROUND
The differential diagnosis of atypical dermal nonepidermotropic CD8
OBJECTIVES
To assess the clinical, histological and immunophenotypic features; outcomes of; and differences between dermal CD8
METHODS
Retrospective analysis of a series of 46 patients and biopsies by the international EORTC Cutaneous Lymphoma Group.
RESULTS
The dermal CD8
CONCLUSIONS
A constellation of distinct clinical, histopathological and phenotypic features allows discrimination and assignment of dermal CD8
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
887-897Informations de copyright
© 2022 British Association of Dermatologists.
Références
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC, 2017.
Kempf W, Mitteldorf C. Pathologic diagnosis of cutaneous lymphomas. Dermatol Clin 2015; 33:655-81.
Willemze R, Cerroni L, Kempf W et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood 2019; 133:1703-14.
Petrella T, Maubec E, Cornillet-Lefebvre P et al. Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma? Am J Surg Pathol 2007; 31:1887-92.
Khamayzi Z, Ben-Arieh Y, Epelbaum R et al. Pleomorphic CD8+ small/medium size cutaneous T-cell lymphoma. Am J Dermatopathol 2006; 28:434-7.
Beltraminelli H, Mullegger R, Cerroni L. Indolent CD8+ lymphoid proliferation of the ear: a phenotypic variant of the small-medium pleomorphic cutaneous T-cell lymphoma? J Cutan Pathol 2010; 37:81-4.
Suchak R, O’Connor S, McNamara C et al. Indolent CD8-positive lymphoid proliferation on the face: part of the spectrum of primary cutaneous small-/medium-sized pleomorphic T-cell lymphoma or a distinct entity? J Cutan Pathol 2010; 37:977-81.
Kempf W, Kazakov DV, Cozzio A et al. Primary cutaneous CD8+ small to medium-sized lymphoproliferative disorder in extrafacial sites - clinicopathological features and concepts on their classification. Am J Dermatopathol 2013; 35:159-66.
Greenblatt D, Ally M, Child F et al. Indolent CD8+ lymphoid proliferation of acral sites: a clinicopathologic study of six patients with some atypical features. J Cutan Pathol 2013; 40:248-58.
Kluk J, Kai A, Koch D et al. Indolent CD8-positive lymphoid proliferation of acral sites: three further cases of a rare entity and an update on a unique patient. J Cutan Pathol 2016; 43:125-36.
Hathuc VM, Hristov AC, Smith LB. Primary cutaneous acral CD8+ T-cell lymphoma. Arch Pathol Lab Med 2017; 141:1469-75.
Tjahjono LA, Davis MDP, Witzig TE et al. Primary cutaneous acral CD8+ T-cell lymphoma - a single center review of 3 cases and recent literature review. Am J Dermatopathol 2019; 41:644-8.
Li JY, Guitart J, Pulitzer MP et al. Multicenter case series of indolent small/medium-sized CD8+ lymphoid proliferations with predilection for the ear and face. Am J Dermatopathol 2014; 36:402-8.
Swerdlow SH, Campo E, Pileri SA et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127:2375-90.
Wobser M, Roth S, Reinartz T et al. CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas. Br J Dermatol 2015; 172:1573-80.
Alberti-Violetti S, Fanoni D, Provasi M et al. Primary cutaneous acral CD8 positive T-cell lymphoma with extra-cutaneous involvement: a long-standing case with an unexpected progression. J Cutan Pathol 2017; 44:964-8.
Toberer F, Christopoulos P, Lasitschka F et al. Double-positive CD8/CD4 primary cutaneous acral T-cell lymphoma. J Cutan Pathol 2019; 46:231-3.
Willemze R, Hodak E, Zinzani PL et al. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018; 29:iv30-iv40.
Maubec E, Marinho E, Laroche L et al. Primary cutaneous acral CD8+ T-cell lymphomas relapse more frequently in younger patients. Br J Haematol 2019; 185:598-601.
Geraud C, Goerdt S, Klemke CD. Primary cutaneous CD8+ small/medium-sized pleomorphic T-cell lymphoma, ear-type: a unique cutaneous T-cell lymphoma with a favourable prognosis. Br J Dermatol 2011; 164:456-8.
Perry AM, Warnke RA, Hu Q et al. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Blood 2013; 122:3599-606.
Plaza JA, Ortega P, Lynott J et al. CD8-positive primary cutaneous anaplastic large T-cell lymphoma (PCALCL): case report and review of this unusual variant of PCALCL. Am J Dermatopathol 2010; 32:489-91.
Magro CM, Crowson AN, Morrison C et al. CD8+ lymphomatoid papulosis and its differential diagnosis. Am J Clin Pathol 2006; 125:490-501.
Bekkenk MW, Vermeer MH, Jansen PM et al. Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients. Blood 2003; 102:2213-19.
Kempf W, Mitteldorf C, Battistella M et al. Primary cutaneous peripheral T-cell lymphoma, not otherwise specified (NOS): results of a multicentre European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico-pathological and prognostic features. J Eur Acad Dermatol Venereol 2021; 35:658-68.
Miano C, Megna M, Di Caterino P et al. An indolent nasal form of primary cutaneous CD8-positive peripheral T-cell lymphoma not otherwise specified successfully treated with local radiation therapy: a new subtype? Dermatol Ther 2021; 34:e14887.
Marzano AV, Berti E, Alessi E et al. Clonal CD8 infiltration of the skin in common variable immunodeficiency: a prelymphomatous stage? J Am Acad Dermatol 2001; 44:710-13.
Riaz IB, Faridi W, Patnaik MM et al. A systematic review on predisposition to lymphoid (B and T cell) neoplasias in patients with primary immunodeficiencies and immune dysregulatory disorders (inborn errors of immunity). Front Immunol 2019; 10:777.
Schuetz C, Huck K, Gudowius S et al. An immunodeficiency disease with RAG mutations and granulomas. N Engl J Med 2008; 358:2030-8.
Berglund LJ, Jones GJ, Murali R et al. TACI mutation with invasive polyclonal CD8+ T-cell lymphoproliferation in a patient with common variable immunodeficiency. J Allergy Clin Immunol 2006; 117:870-7.
Avitan-Hersh E, Stepensky P, Zaidman I et al. Primary cutaneous clonal CD8+ T-cell lymphoproliferative disorder associated with immunodeficiency due to RAG1 mutation. Am J Dermatopathol 2020; 42:e11-15.
Gualdi G, Lorenzi L, Arisi M et al. Acral lympho-histiocytic dermatitis in X-linked agammaglobulinemia: a case report showing clonal CD8+ T cells with indolent clinical behaviour. J Eur Acad Dermatol Venereol 2016; 30:461-3.
Gammon B, Robson A, Deonizio J et al. CD8+ granulomatous cutaneous T-cell lymphoma: a potential association with immunodeficiency. J Am Acad Dermatol 2014; 71:555-60.
Amann VC, Dreier J, Ignatova D et al. Disseminated primary cutaneous CD8+ small/medium-sized pleomorphic T-cell lymphoma responding to hydroxychloroquine. Acta Derm Venereol 2015; 95:602-3.
Lu D, Patel KA, Duvic M et al. Clinical and pathological spectrum of CD8-positive cutaneous T-cell lymphomas. J Cutan Pathol 2002; 29:465-72.